This program explores how serum IgA occasionally permits bacterial bloodstream survival as it modulates the immune response to enteric antigens. Serum IgA is induced by enteric bacteria that are processed through Peyer's patches: it is cleared through the liver. Blockade of complement (c) mediated bacterial clearance by serum IgA plays a role in the pathogenesis of epidemic meningococcal disease and may be involved in that of gonococcal, Haemophilus and streptococcal infections, as well. It is also probable that it contributes to sepsis during severe hepatic cirrhosis. Understanding the function of serum IgA requires a better knowledge of how C is activated on bacterial surfaces. Lysis of neisseria requires recognition of the cell surface by either antibody or c. Properdin (P) is necessary for C-recognition in the absence of specific antibody; P binding augments antibody-initiated lysis through the classical C pathway. Studies planned for the next five years address the molecular mechanism of IgA blockade. They focus on interactions between alternative C pathway components and carbohydrate moieties of immunoglobulins and on bacterial surfaces. the chemical basis of P-recognition will be sought by assessing the ability of native and modified capsular polysaccharides (PS) on inhibit binding of P by zymosan, a highly branched mannose polymer; and by determining the gonococcal cell-surface receptor for P. We will look for a P receptor within PS and oligosaccharides (OS) and on the OS of IgG and IgA. We will use FACS of neisseria tagged with McAb and C components to find out how capsular PS expression influences binding of P and of factors B, H, and I, and what effect PS-specific IgG and IgA have on their binding. We will use mass spectrometry to structure OS that are enzymatically released from myeloma and polyclonal IgA and IgG, and compare the ability of these and other structurally defined and chemically altered OS, to inhibit lysis. We will use monoclonal Abs of different specificities to determine whether IgA blockade is necessarily Ag-specific.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI021171-08
Application #
2061426
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Project Start
1983-09-30
Project End
1994-12-31
Budget Start
1993-01-01
Budget End
1994-12-31
Support Year
8
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Pathology
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
McLeod Griffiss, J; Brandt, B L; Saunders, N B et al. (2000) Structural relationships and sialylation among meningococcal L1, L8, and L3,7 lipooligosaccharide serotypes. J Biol Chem 275:9716-24
Hamadeh, R M; Galili, U; Zhou, P et al. (1995) Anti-alpha-galactosyl immunoglobulin A (IgA), IgG, and IgM in human secretions. Clin Diagn Lab Immunol 2:125-31
Jarvis, G A (1995) Recognition and control of neisserial infection by antibody and complement. Trends Microbiol 3:198-201
Hamadeh, R M; Estabrook, M M; Zhou, P et al. (1995) Anti-Gal binds to pili of Neisseria meningitidis: the immunoglobulin A isotype blocks complement-mediated killing. Infect Immun 63:4900-6
Jarvis, G A (1994) Analysis of C3 deposition and degradation on Neisseria meningitidis and Neisseria gonorrhoeae. Infect Immun 62:1755-60
Wetter, L A; Hamadeh, R M; Griffiss, J M et al. (1994) Differences in outer membrane characteristics between gallstone-associated bacteria and normal bacterial flora. Lancet 343:444-8
Hamadeh, R M; Jarvis, G A; Galili, U et al. (1992) Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces. J Clin Invest 89:1223-35
Jarvis, G A; Griffiss, J M (1991) Human IgA1 blockade of IgG-initiated lysis of Neisseria meningitidis is a function of antigen-binding fragment binding to the polysaccharide capsule. J Immunol 147:1962-7
Griffiss, J M; Yamasaki, R; Estabrook, M et al. (1991) Meningococcal molecular mimicry and the search for an ideal vaccine. Trans R Soc Trop Med Hyg 85 Suppl 1:32-6
Jarvis, G A; Griffiss, J M (1989) Human IgA1 initiates complement-mediated killing of Neisseria meningitidis. J Immunol 143:1703-9

Showing the most recent 10 out of 19 publications